Pfizer Inc. (PFE)
29.88
-0.91
(-2.96%)
USD |
NYSE |
Nov 05, 16:00
29.89
+0.01
(+0.03%)
Pre-Market: 20:00
Pfizer Price : 29.88 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 31.09 | 31.44 | 29.85 | 29.88 | 53.05M |
| Nov 04, 2026 | 30.75 | 30.90 | 30.04 | 30.79 | 49.92M |
| Nov 03, 2026 | 30.68 | 31.06 | 29.89 | 30.00 | 53.06M |
| Nov 02, 2026 | 30.45 | 31.04 | 30.20 | 30.67 | 50.82M |
| Oct 30, 2026 | 30.51 | 30.67 | 30.14 | 30.52 | 45.49M |
| Oct 29, 2026 | 29.99 | 30.18 | 29.61 | 29.95 | 34.26M |
| Oct 28, 2026 | 29.49 | 29.82 | 29.22 | 29.45 | 27.26M |
| Oct 27, 2026 | 29.54 | 29.86 | 29.51 | 29.80 | 25.59M |
| Oct 26, 2026 | 30.00 | 30.30 | 29.72 | 29.79 | 25.66M |
| Oct 23, 2026 | 30.28 | 30.32 | 29.81 | 30.03 | 29.48M |
| Oct 22, 2026 | 30.04 | 30.44 | 29.88 | 30.42 | 28.70M |
| Oct 21, 2026 | 30.00 | 30.09 | 29.69 | 29.85 | 22.22M |
| Oct 20, 2026 | 29.67 | 30.25 | 29.59 | 30.11 | 34.44M |
| Oct 19, 2026 | 29.30 | 29.69 | 29.25 | 29.44 | 20.82M |
| Oct 16, 2026 | 29.72 | 29.74 | 29.42 | 29.58 | 28.63M |
| Oct 15, 2026 | 29.57 | 29.88 | 29.42 | 29.44 | 32.89M |
| Oct 14, 2026 | 28.60 | 29.49 | 28.55 | 29.21 | 39.37M |
| Oct 13, 2026 | 28.61 | 28.61 | 28.13 | 28.37 | 26.84M |
| Oct 12, 2026 | 28.42 | 28.50 | 28.28 | 28.40 | 18.56M |
| Oct 09, 2026 | 27.61 | 28.28 | 27.59 | 28.28 | 23.20M |
| Oct 08, 2026 | 27.90 | 28.00 | 27.48 | 27.82 | 44.43M |
| Oct 07, 2026 | 27.62 | 28.17 | 27.55 | 28.00 | 31.23M |
| Oct 06, 2026 | 27.48 | 27.71 | 27.20 | 27.50 | 24.07M |
| Oct 05, 2026 | 27.65 | 27.72 | 27.12 | 27.41 | 33.01M |
| Oct 02, 2026 | 28.14 | 28.16 | 27.44 | 27.80 | 35.01M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 272.32 |
| Eli Lilly & Co. | 1364.73 |
| Merck & Co., Inc. | 146.94 |
| Bristol Myers Squibb Co. | 63.13 |
| Viatris, Inc. | 18.97 |
Price Related Metrics
| PE Ratio | 42.73 |
| PS Ratio | 2.685 |
| Price to Book Value | 1.914 |
| Price to Free Cash Flow | 14.49 |
| Earnings Yield | 2.34% |
| Market Cap | 170.32B |
| Operating PE Ratio | 10.34 |
| Normalized PE Ratio | 13.17 |